
Ascendis Pharma A/S
NASDAQ:ASND

Intrinsic Value
The intrinsic value of one
ASND
stock under the Base Case scenario is
210.45
USD.
Compared to the current market price of 173.07 USD,
Ascendis Pharma A/S
is
Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Ascendis Pharma A/S
Fundamental Analysis


Revenue & Expenses Breakdown
Ascendis Pharma A/S
Balance Sheet Decomposition
Ascendis Pharma A/S
Current Assets | 921.5m |
Cash & Short-Term Investments | 517.9m |
Receivables | 76.8m |
Other Current Assets | 326.7m |
Non-Current Assets | 140m |
Long-Term Investments | 40.9m |
PP&E | 92.4m |
Intangibles | 3.9m |
Other Non-Current Assets | 2.7m |
Free Cash Flow Analysis
Ascendis Pharma A/S
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Ascendis Pharma A/S
Revenue
|
368.7m
EUR
|
Cost of Revenue
|
-54.2m
EUR
|
Gross Profit
|
314.5m
EUR
|
Operating Expenses
|
-640.8m
EUR
|
Operating Income
|
-326.3m
EUR
|
Other Expenses
|
-15.4m
EUR
|
Net Income
|
-341.7m
EUR
|
ASND Profitability Score
Profitability Due Diligence
Ascendis Pharma A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Score
Ascendis Pharma A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
ASND Solvency Score
Solvency Due Diligence
Ascendis Pharma A/S's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Score
Ascendis Pharma A/S's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ASND Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for
ASND
is 228.23 USD
with a low forecast of 195.94 USD and a high forecast of 303.45 USD.
Dividends
Current shareholder yield for ASND is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ASND
stock under the Base Case scenario is
210.45
USD.
Compared to the current market price of 173.07 USD,
Ascendis Pharma A/S
is
Undervalued by 18%.